Terremoto Biosciences is a covalent drug discovery and development engine creating highly targeted, small molecule medicines with unmatched selectivity, potency and efficacy. The company leverages the power of lysine-based covalency across the disease spectrum to develop both best-in-class therapies against known drug targets and first-in-class medicines against the previously undruggable. Many of Terremoto’s founders helped establish this emergent area of science, with the intent to broaden the number of tractable targets and deliver medicines with superior therapeutic benefit. Terremoto is supported by leading investors OrbiMed and Third Rock Ventures. More information is available at www.terremotobio.com.
Company Details
- Employees
- 75
- Address
- South San Francisco, California 94080, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.terremotobio.com
- Keywords
- future collaborations!.
- HQ
- South San Francisco, California
Terremoto Biosciences Questions
Terremoto Biosciences's website is http://www.terremotobio.com
Terremoto Biosciences's LinkedIn profile is https://www.linkedin.com/company/terremoto-biosciences
Terremoto Biosciences has
75 employees.
View email and phone details for 75
employees at Terremoto Biosciences.
Terremoto Biosciences's industry is
Biotechnology Research
Terremoto Biosciences's top competitors are
Gate Bioscience,
Maze Therapeutics,
Bridgebio,
Aro Biotherapeutics,
Orsobio,
Allogene Therapeutics,
Blackbird Laboratories,
Vivodyne,
Arsenal Biosciences, Inc.,
Septerna.
Terremoto Biosciences's categories are Biotechnology Research
